Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

SpringWorks Therapeutics (SWTX) had Revenue of $191.59M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$191.59M
Net Income	$-258.13M
Cost of Goods Sold	$12.55M
Gross Profit	$179.04M
Operating Expenses	$469.72M
Operating Income	$-278.13M
Non-Operating Income/Expense	$20.00M
Pre-Tax Income	$-258.13M
Normalized Pre-Tax Income	$-258.13M
Income after Taxes	$-258.13M
Income from Continuous Operations	$-258.13M
Consolidated Net Income/Loss	$-258.13M
Normalized Income after Taxes	$-258.13M
EBIT	$-278.13M
EBITDA	$-274.66M
Weighted-Average Shares Outstanding (Basic)	74.13M
Weighted-Average Shares Outstanding (Diluted)	74.13M
Earnings per Share (EPS) (Basic)	$-3.48
Earnings per Share (EPS) (Diluted)	$-3.48
Balance Sheet Financials
Current Assets	$380.46M
Property, Plant, and Equipment	$19.68M
Long-Term Assets	$206.81M
Total Assets	$587.28M
Current Liabilities	$99.99M
Long-Term Debt	--
Long-Term Liabilities	$6.18M
Total Liabilities	$106.17M
Common Equity	$481.10M
Tangible Shareholders Equity	$481.10M
Shareholders Equity	$481.10M
Common Shares Outstanding	74.40M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-175.60M
Cash Flow from Investing Activities	$64.55M
Cash Flow from Financial Activities	$4.76M
Beginning Cash	$176.67M
End Cash	$70.38M
Increase/Decrease in Cash	$-106.29M
Stock-Based Compensation	$109.14M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.81
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	93.45%
Operating Margin	-145.17%
EBIT Margin	-145.17%
EBITDA Margin	-143.36%
Pre-Tax Profit Margin	-134.73%
Profit Margin	-134.73%
Free Cash Flow	$-180.05M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.33
Inventory Turnover	1.23
Receiveable Turnover	4.14
Days Sales in Receivables	88.09
Return on Equity	-53.65%
Return on Tangible Equity	-53.65%
Return on Assets	-43.95%
Return on Investments	-53.65%
Book Value Per Share	$6.47
Free Cash Flow per Share	$-2.43
Operating Cash Flow per Share	$-2.37

Data from Zacks Investment Research, Inc.